Variant report
Variant | esv3343881 |
---|---|
Chromosome Location | chr5:9597590-9598727 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:9593037..9596912-chr5:9597409..9600485,3 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547821560 | chr5:9597631-9597632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs13359458 | chr5:9597659-9597660 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs536414632 | chr5:9597665-9597666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556412122 | chr5:9597686-9597687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185869192 | chr5:9597688-9597689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189846402 | chr5:9597725-9597726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558267311 | chr5:9597732-9597733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182320548 | chr5:9597826-9597827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143696036 | chr5:9597839-9597840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554615820 | chr5:9597900-9597901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs60926143 | chr5:9597905-9597906 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs542790816 | chr5:9597950-9597951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151038044 | chr5:9597994-9597995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200864636 | chr5:9597998-9597999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6870771 | chr5:9598097-9598098 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs545339282 | chr5:9598107-9598108 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376546451 | chr5:9598123-9598124 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565440997 | chr5:9598170-9598171 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151044316 | chr5:9598187-9598188 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547488282 | chr5:9598218-9598219 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561402159 | chr5:9598219-9598220 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114995561 | chr5:9598315-9598316 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140927385 | chr5:9598358-9598359 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73740694 | chr5:9598368-9598369 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs186315991 | chr5:9598379-9598380 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6897403 | chr5:9598383-9598384 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs565852711 | chr5:9598391-9598392 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372793001 | chr5:9598416-9598417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534584502 | chr5:9598466-9598467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150281938 | chr5:9598475-9598476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574179157 | chr5:9598489-9598490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191112504 | chr5:9598505-9598506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139014717 | chr5:9598525-9598526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs194086 | chr5:9598537-9598538 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs373379982 | chr5:9598550-9598551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561614044 | chr5:9598562-9598563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183999067 | chr5:9598601-9598602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565536977 | chr5:9598632-9598633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572669884 | chr5:9598648-9598649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541390834 | chr5:9598667-9598668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561169354 | chr5:9598675-9598676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:9595000-9598200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:9595400-9598200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
3 | chr5:9595600-9598000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr5:9595600-9598000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr5:9596000-9597600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:9596200-9597800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr5:9596800-9597800 | Enhancers | Esophagus | oesophagus |
8 | chr5:9597000-9598000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:9597200-9599000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:9597200-9599600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr5:9597200-9599800 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr5:9597200-9601400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr5:9597200-9601600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr5:9597400-9598800 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
15 | chr5:9597400-9600200 | Weak transcription | Brain Germinal Matrix | brain |
16 | chr5:9598000-9598200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
17 | chr5:9598000-9598400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr5:9598000-9599200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
19 | chr5:9598200-9599000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
20 | chr5:9598200-9599400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr5:9598200-9600000 | Enhancers | Stomach Mucosa | stomach |
22 | chr5:9598400-9598800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |